Skip to main content
OpenTrials

Clinical trial condition

Otorhinolaryngologic Diseases

Explore clinical trials studying Otorhinolaryngologic Diseases. Study availability and eligibility vary by location and protocol.

5,424 public trials 861 recruiting studies
Refine in advanced search Browse all conditions

Otorhinolaryngologic Diseases trial results

Active, Not Recruiting

A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

NCT06706817

Conditions
Chronic Rhinosinusitis With Nasal Polyps, Infections, Nose Diseases, +7 more
Locations
  • Research Site Newport Beach, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Chestnut Hill, Massachusetts, United States
  • Research Site Columbia, Missouri, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma

NCT05784012

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
Locations
  • Institut Catalá d'Oncologia (ICO) BADALONA Badalona, Catalonia, Spain
  • Hospital Universitario Valle Hebron Barcelona, Catalonia, Spain
  • Hospital Clinic de Barcelona Barcelona, Catalonia, Spain
  • Institut Catalá d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Catalonia, Spain
View Trial Details
Active, Not Recruiting

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population

NCT06293482

Conditions
Ear Diseases, Hearing Disorders, Hearing Loss, +8 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Centre for Neurosciences Tucson, Arizona, United States
  • Pacific Neuroscience Institute Santa Monica, California, United States
  • University of Miami Coral Gables, Florida, United States
View Trial Details
Active, Not Recruiting

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

NCT04590963

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Westwood, Kansas, United States
  • Research Site Boston, Massachusetts, United States
View all 127 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

NCT05211232

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations
  • The Affiliated Hospital of Guangdong Medical College Zhanjiang, Guangdong, China
  • Wuzhou Red Cross Hospital Wuzhou, Guangxi, China
  • Guizhou Cancer Hospital Guiyang, Guizhou, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View Trial Details

Related conditions